Beaumont RCSI Cancer Centre

2022 Cancer Conference and Accreditation Event

July 20, 2022 | Blog
2022 Cancer Conference and Accreditation Event

As Ireland’s newly accredited European Cancer Centre, the Beaumont RCSI Cancer Centre, will hold its first conference in Dublin on Thursday, 22 September 2022.

The conference is the first of its kind to be held by the Centre, which is an innovative collaboration between Beaumont Hospital, RCSI University of Medicine and Health Sciences and St Luke’s Radiation Oncology Network.

The Beaumont RCSI Cancer Centre has recently been accredited by the OECI, Europe’s accreditation body for standards in cancer research, education and clinical care.

The inaugural cancer conference will bring together healthcare professionals, academics and key stakeholders to celebrate the accreditation and present the Cancer Centre’s vision for comprehensive cancer care in Ireland.

International key note speakers include Professor Alastair Thompson, Breast Cancer Surgeon and Professor and Chief, Section of Breast Surgery, Baylor College of Medicine and Dr Jean-Benoît Burrion, Chair of the OECI Accreditation and Designation Programme.

The Beaumont RCSI Cancer Centre is a partnership between Ireland’s leading healthcare professionals, academics, biologists, epidemiologists and statisticians across the disciplines of medicine, radiation, surgery and palliative care. The Centre specialises in the treatment of a wide range of cancers including breast, colorectal, lung, endocrine, head & neck, neuro oncology, urology, skin, haematology and upper gastro intestinal.

Commenting on the significance of the event, Professor Patrick Morris, Medical Director of the Beaumont RCSI Cancer Centre said: “The establishment of the Beaumont RCSI Cancer Centre formalises the alliance and commitment to cancer care that has long existed between the three partners involved, combining our expertise to create a centre of excellence with the scale and breadth to drive improvements nationally and through our international networks.”

Professor Leonie Young, Scientific Director of the Beaumont RCSI Cancer Centre, said: “A key goal of Beaumont RCSI Cancer Centre is to integrate world-class research and clinical education into the treatment of patients across all types of cancer. This conference is an important part of this strategy and will be of interest to the vast number of people who have been affected by cancer and their families as well as everyone in involved in the research and treatment of all forms of cancer in Ireland and worldwide.’

For further information on how to register and submit abstracts visit the conference webpage